Literature DB >> 28462772

Mixed features in major depressive disorder: diagnoses and treatments.

Trisha Suppes1, Michael Ostacher1.   

Abstract

For the first time in 20 years, the American Psychiatric Association (APA) updated the psychiatric diagnostic system for mood disorders in the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5). Perhaps one of the most notable changes in the DSM-5 was the recognition of the possibility of mixed symptoms in major depression and related disorders (MDD). While MDD and bipolar and related disorders are now represented by 2 distinct chapters, the addition of a mixed features specifier to MDD represents a structural bridge between bipolar and major depression disorders, and formally recognizes the possibility of a mix of hypomania and depressive symptoms in someone who has never experienced discrete episodes of hypomania or mania. This article reviews historical perspectives on "mixed states" and the recent literature, which proposes a range of approaches to understanding "mixity." We discuss which symptoms were considered for inclusion in the mixed features specifier and which symptoms were excluded. The assumption that mixed symptoms in MDD necessarily predict a future bipolar course in patients with MDD is reviewed. Treatment for patients in a MDD episode with mixed features is critically considered, as are suggestions for future study. Finally, the premise that mood disorders are necessarily a spectrum or a gradient of severity progressing in a linear manner is argued.

Entities:  

Keywords:  Atypical antipsychotics; diagnosis; major depression; mixed features; mixed symptoms; mood disorders; treatment

Mesh:

Substances:

Year:  2017        PMID: 28462772     DOI: 10.1017/S1092852917000256

Source DB:  PubMed          Journal:  CNS Spectr        ISSN: 1092-8529            Impact factor:   3.790


  5 in total

1.  Associations of presenting symptoms and subsequent adverse clinical outcomes in people with unipolar depression: a prospective natural language processing (NLP), transdiagnostic, network analysis of electronic health record (EHR) data.

Authors:  Rashmi Patel; Jessica Irving; Aimee Brinn; Matthew Taylor; Hitesh Shetty; Megan Pritchard; Robert Stewart; Paolo Fusar-Poli; Philip McGuire
Journal:  BMJ Open       Date:  2022-04-29       Impact factor: 3.006

2.  Treatment of mixed depression with theta-burst stimulation (TBS): results from a double-blind, randomized, sham-controlled clinical trial.

Authors:  Diego Freitas Tavares; Paulo Suen; Carla Garcia Rodrigues Dos Santos; Doris Hupfeld Moreno; Leandro Da Costa Lane Valiengo; Izio Klein; Lucas Borrione; Pamela Marques Forte; André R Brunoni; Ricardo Alberto Moreno
Journal:  Neuropsychopharmacology       Date:  2021-06-30       Impact factor: 7.853

Review 3.  Depression Preceding Diagnosis of Bipolar Disorder.

Authors:  Claire O'Donovan; Martin Alda
Journal:  Front Psychiatry       Date:  2020-06-11       Impact factor: 4.157

Review 4.  Pharmacological Treatment of Major Depressive Episodes with Mixed Features: A Systematic Review.

Authors:  In Hee Shim; Won-Myong Bahk; Young Sup Woo; Bo-Hyun Yoon
Journal:  Clin Psychopharmacol Neurosci       Date:  2018-11-30       Impact factor: 2.582

Review 5.  Mixed Depression: A Mini-Review to Guide Clinical Practice and Future Research Developments.

Authors:  Antimo Natale; Ludovico Mineo; Laura Fusar-Poli; Andrea Aguglia; Alessandro Rodolico; Massimo Tusconi; Andrea Amerio; Gianluca Serafini; Mario Amore; Eugenio Aguglia
Journal:  Brain Sci       Date:  2022-01-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.